FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Dismiss Norwich Rifaximin Suit: FDA

FDA tells the DC federal court there are five reasons why it should dismiss a Norwich suit seeking to force the agency to approve an amended ANDA for ...

latest-news-card-1
Medical Devices

MediView Surgical Augmented Reality Device Cleared

FDA clears a MediView XR 510(k) for its XR90 augmented reality-based surgical visualization and navigation platform.

latest-news-card-1
Human Drugs

Using ctDNA as an Early Endpoint

Panelists at a Friends of Cancer Research meeting discuss the next steps to help make circulating tumor DNA available as an early endpoint in cancer r...

latest-news-card-1
Medical Devices

Bone Bolt System Cleared by FDA

FDA clears a University of Utah Orthopedic Innovation Center 510(k) for its Bone Bolt System, an implant for percutaneous bone fracture fixation.

latest-news-card-1
Human Drugs

FDA Monitoring Drug Shortages After Pfizer Tornado

FDA says it is working with Pfizer to monitor the potential for drug shortages after a 7/19 tornado severely damaged Pfizers large sterile injectables...

latest-news-card-1
Federal Register

Info Collection on Blood Product GMPs

Federal Register notice: FDA sends to OMB an information collection revision entitled Current Good Manufacturing Practice for Blood and Blood Componen...

latest-news-card-1
Federal Register

FDA Announces 7 Info Collections Approved

Federal Register notice: FDA announces that seven information collections have been approved by OMB.

latest-news-card-1
Human Drugs

Astria Gets Fast Track for Angioedema Drug

FDA grants Astria Therapeutics fast track status for STAR-0215 for treating hereditary angioedema.

latest-news-card-1
Human Drugs

FDA OKs Vanflyta for Leukemia

FDA approves a Daiichi Sankyo NDA for Vanflyta (quizartinib) in certain patients with newly diagnosed acute myeloid leukemia.

latest-news-card-1
Human Drugs

New FDA Tools in Democrats Preparedness Bill

All Democrats on the House Energy and Commerce Committee sponsor legislation to reauthorize the Pandemic and All-Hazards Preparedness Act and give FDA...